| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| abi-011 | hepatocyte growth factor | NA | Clinical trial target | TTD , DGIDB | Ankle brachial pressure index (observable entity)[MeSHID:D055109] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
| abi-011 | dna topoisomerase i | NA | Successful target | TTD , DGIDB | Ankle brachial pressure index (observable entity)[MeSHID:D055109] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
| abi-011 | vascular endothelial growth factor a | NA | Successful target | TTD , DGIDB | Ankle brachial pressure index (observable entity)[MeSHID:D055109] Malignant Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma[MeSHID:D008223] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||